SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2024-03-28 10:49
Tx date 2024-03-25
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+72,222 vol
72,222
Filed 2024-03-28 10:49
Tx date 2020-01-22
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-03-28 10:49
Tx date 2024-03-25
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase

-38,889 vol
222,222
Filed 2024-03-28 10:48
Tx date 2024-03-25
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-72,222 vol
261,111
Older filings
Filed 2024-03-18 11:52
Tx date 2024-03-14
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+333,333 vol
333,333
Filed 2024-03-18 11:51
Tx date 2020-01-22
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-15 15:06
Tx date 2023-08-11
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+225,000 vol
775,000
Filed 2021-09-09 14:43
Tx date 2021-09-02
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
550,000
Filed 2020-04-30 20:51
Tx date 2020-04-19
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+400,000 vol
400,000
Filed 2020-04-30 15:56
Tx date 2020-01-22
$INNO
InnoCan Pharma Corporation
Bloch, Peter David
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report